LOCUMOSES LTD

Company Registration Number:
14017806 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2024

Period of accounts

Start date: 01 May 2023

End date: 30 April 2024

LOCUMOSES LTD

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

LOCUMOSES LTD

Company Information

for the Period Ended 30 April 2024




Director: Faye Moses
Registered office: 4
Sandringham Crescent
Sunderland
England
SR3 3PT
Company Registration Number: 14017806 (England and Wales)

LOCUMOSES LTD

Directors' Report Period Ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Principal Activities

Pharmacy locum services

Directors

The directors shown below have held office during the whole of the period from 01 May 2023 to 30 April 2024
Faye Moses

This report was approved by the board of directors on 19 January 2025
And Signed On Behalf Of The Board By:

Name: Faye Moses
Status: Director

LOCUMOSES LTD

Profit and Loss Account

for the Period Ended 30 April 2024


Notes

2024
£
13 months to
30 Apr 2023
£
Turnover 18,801 38,538
Cost of sales ( 0 ) ( 0 )
Gross Profit or (Loss) 18,801 38,538
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 1,539 ) ( 1,063 )
Operating Profit or (Loss) 17,262 37,475
Interest Receivable and Similar Income 51 -
Interest Payable and Similar Charges ( 0 ) ( 0 )
Profit or (Loss) Before Tax 17,313 37,475
Tax on Profit ( 3,288 ) ( 7,119 )
Profit or (Loss) for Period 14,025 30,356

The notes form part of these financial statements

LOCUMOSES LTD

Balance sheet

As at 30 April 2024


Notes

2024
£
13 months to
30 Apr 2023
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 3,500 7,300
Total current assets: 3,500 7,300
Net current assets (liabilities): 3,500 7,300
Total assets less current liabilities: 3,500 7,300
Provision for liabilities: ( 3,499 ) ( 7,299 )
Total net assets (liabilities): 1 1

The notes form part of these financial statements

LOCUMOSES LTD

Balance sheet continued

As at 30 April 2024


Notes

2024
£
13 months to
30 Apr 2023
£
Capital and reserves
Called up share capital: 1 1
Shareholders funds: 1 1

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 January 2025
And Signed On Behalf Of The Board By:

Name: Faye Moses
Status: Director

The notes form part of these financial statements

LOCUMOSES LTD

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

LOCUMOSES LTD

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Employees


    2024
    13 months to
    30 Apr 2023
    Average number of employees during the period 1 1

LOCUMOSES LTD

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 3. Off balance sheet disclosure

    No